Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer Sells 900 Shares

Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer sold 900 shares of Trupanion stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $54.55, for a total value of $49,095.00. Following the transaction, the senior vice president now owns 23,808 shares in the company, valued at approximately $1,298,726.40. This represents a 3.64 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Emily Dreyer also recently made the following trade(s):

• On Friday, November 22nd, Emily Dreyer sold 3,100 shares of Trupanion stock. The stock was sold at an average price of $54.85, for a total value of $170,035.00.

Trupanion Trading Up 1.7 %

TRUP opened at $54.35 on Wednesday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The business’s 50-day simple moving average is $49.35 and its 200 day simple moving average is $39.87. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.09. The firm had revenue of $327.50 million for the quarter, compared to analyst estimates of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.10) earnings per share. As a group, equities research analysts forecast that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on TRUP. Piper Sandler boosted their price target on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Stifel Nicolaus boosted their price target on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Bank of America boosted their price target on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. Finally, Northland Securities boosted their price target on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Trupanion presently has an average rating of “Moderate Buy” and an average target price of $44.67.

Institutional Trading of Trupanion

Institutional investors and hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC bought a new stake in Trupanion in the second quarter valued at approximately $4,739,000. Marshall Wace LLP increased its stake in shares of Trupanion by 11.9% during the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after purchasing an additional 116,496 shares during the period. Connors Investor Services Inc. increased its stake in shares of Trupanion by 31.3% during the second quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock worth $3,339,000 after purchasing an additional 27,042 shares during the period. Dalton Investments Inc. bought a new position in shares of Trupanion during the second quarter worth approximately $1,029,000. Finally, OmniStar Financial Group Inc. bought a new position in shares of Trupanion during the third quarter worth approximately $535,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.